The FDA is poised to clear a fourth dose of the mRNA coronavirus vaccine for adults age 50 and older, looking to shore up protections for more vulnerable groups, a person familiar with the matter said.
The move comes as the Biden administration is warning of waning supplies in its fight against the virus and is calling on Congress to authorize new funding. The U.S. does not have enough vaccines to give everyone a fourth dose of mRNA vaccine, officials have said.
The Centers for Disease Control and Prevention would have to make a final ruling on any recommendation by the FDA.» READ MORE:Vaccinations in the U.S. are at their lowest point since the start of the immunization drive in December 2020, according to the Bloomberg Vaccine Tracker. At least 559 million doses have been administered in the U.S. since rollout began. Over 80% of people in the U.S. who are eligible have received at least one dose of vaccine, with almost 70% of those eligible are defined by the CDC as fully vaccinated. Trials are still underway for children under 5, not now eligible for vaccination.
A recent report by the CDC found that protection against COVID-19 waned slightly in the months following a third dose of the vaccine. The booster shot resulted in a 91% decrease in hospitalizations for people who received the booster two months prior to getting sick, and 78% for those who received the booster four or five months prior to contracting the virus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA expected to OK additional Covid-19 booster shots for adults over 50 next weekTwo sources familiar with the government's plans said the US Food and Drug Administration is planning authorize a fourth dose of the Pfizer and Moderna mRNA vaccines for adults over age 50 next week.
Read more »
FDA expected to authorize a second Covid booster shot next weekFDA expected to authorize a second Covid booster shot next week. The New York Times, which first reported the news, said late Friday that the Biden administration planned to offer second boosters to Americans age 50 and older.
Read more »
FDA expected to authorize second coronavirus booster for 50 and olderThe FDA is poised to authorize a second coronavirus vaccine booster for anyone 50 and older. It would provide an extra layer of protection amid concerns Europe’s rise in infections from an omicron subvariant could hit the United States.
Read more »
Nationwide recall of Milk of Magnesia due to possible bacterial contamination: FDAThe popular over-the-counter product for heartburn and constipation could cause intestinal distress instead if it's from the contaminated lots.
Read more »
FDA: Nationwide recall of Milk of Magnesia, other medicines due to possible contaminationPlastikon Healthcare, based in Kansas, is voluntarily recalling a select number of products sold nationally due to possible bacteria contamination.
Read more »